Enhancers of mesenchymal stem cell stemness and therapeutic potency
Authors:
Open Access
- 9 April 2023
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 162, 114356
Abstract
No abstract availableKeywords
Funding Information
- Guangzhou Women and Childrens Medical Center
- Guangzhou Institute of Pediatrics, Guangzhou Women and Childrens Medical Center
This publication has 167 references indexed in Scilit:
- The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicineNature Medicine, 2013
- Carvedilol Enhances Mesenchymal Stem Cell Therapy for Myocardial Infarction via Inhibition of Caspase-3 ExpressionThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Multipotent mesenchymal stromal cells and the innate immune systemNature Reviews Immunology, 2012
- IL-3 promotes osteoblast differentiation and bone formation in human mesenchymal stem cellsBiochemical and Biophysical Research Communications, 2012
- Fullerol antagonizes dexamethasone‐induced oxidative stress and adipogenesis while enhancing osteogenesis in a cloned bone marrow mesenchymal stem cellJournal of Orthopaedic Research, 2012
- Targeting the mTOR kinase domain: the second generation of mTOR inhibitorsDrug Discovery Today, 2011
- Mesenchymal Stem CellsCell Transplantation, 2011
- Mesenchymal Stem Cells as TherapeuticsAnnual Review of Biomedical Engineering, 2010
- IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarctionProceedings of the National Academy of Sciences, 2009
- Mesenchymal Stem Cells Derived from Dental Tissues vs. Those from Other Sources: Their Biology and Role in Regenerative MedicineJournal of Dental Research, 2009